“Improvement of risk assessment in cutaneous melanoma (CM) by a prognostic 31-gene expression profile (31-GEP) test over AJCC-based staging alone”, J of Skin, vol. 2, p. S70, Dec. 2018, doi: 10.25251/skin.2.supp.70.